Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Childhood psoriasis.

E M Farber1, L Nall

  • 1Department of Dermatology, Stanford University School of Medicine, California, USA.

Cutis
|December 3, 1999
PubMed
Summary
This summary is machine-generated.

Childhood psoriasis, affecting infants to adolescents, involves genetic and environmental factors. Treatment focuses on safe, effective therapies to manage this common pediatric skin condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical testing of new drugs for lesional skin diseases such as psoriasis A new delivery system.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2016
Same author

Evaluation of beta-dimethylaminoethyl benzhydryl ether hydrochloride (benadryl) in the treatment of urticaria, scleroderma and allied disturbances.

Proceedings of the staff meetings. Mayo Clinic·2010
Same author

Ulcer of the leg due to arteriolosclerosis and ischemia, occurring in the presence of hypertensive disease (hypertensive-ischemic ulcers).

Proceedings of the staff meetings. Mayo Clinic·2010
Same author

Benadryl in the treatment of urticaria.

Proceedings of the staff meetings. Mayo Clinic·2010
Same author

Ulcer of the leg due to arteriosclerosis and ischemia occurring in the presence of hypertensive disease (hypertensive-ischemic ulcers) a preliminary report.

Proceedings [of the] annual meeting. Central Society for Clinical Research (U.S.)·2010
Same author

Benadryl in the treatment of certain diseases of the skin.

Journal of the American Medical Association·2010
Same journal

Black Dots on the Scalp of a Child.

Cutis·2026
Same journal

Psoriasis and Obesity: A Clinical Review of the Bidirectional Link and Management Implications.

Cutis·2026
Same journal

Adalimumab in Lichen Planus: A Narrative Review of Treatment and Paradoxical Reactions.

Cutis·2026
Same journal

The Future of Psoriasis Care.

Cutis·2026
Same journal

Evaluating GPT-4o for Automated Classification of Skin Lesions Using the HAM10000 Dataset.

Cutis·2026
Same journal

Metastatic Primary Extramammary Paget Disease: A Case Series.

Cutis·2026
See all related articles

Area of Science:

  • Pediatric Dermatology
  • Immunodermatology
  • Genetics of Skin Diseases

Background:

  • Psoriasis is a prevalent chronic inflammatory skin condition affecting pediatric populations.
  • Onset in childhood (birth to 18 years) suggests interplay between genetic predisposition and environmental triggers.
  • Understanding childhood psoriasis is crucial due to its potential impact on development and quality of life.

Purpose of the Study:

  • To present a comprehensive review of childhood psoriasis.
  • To cover clinical presentation, epidemiology, genetics, and therapeutic strategies.
  • To consolidate current knowledge for healthcare providers managing pediatric psoriasis.

Main Methods:

  • Literature review synthesizing data on pediatric psoriasis.

Related Experiment Videos

  • Analysis of clinical, epidemiological, and genetic studies.
  • Evaluation of therapeutic options for childhood psoriasis.

    • Main Results:

    • Childhood psoriasis is influenced by genetic and environmental factors, with Koebner reactions playing a role.
    • Common variants include plaque and guttate psoriasis; rare forms like pustular and erythrodermic psoriasis also occur.
    • Scalp, extremities, trunk, and nails are frequently affected; face and ears are notable in pediatric cases.

    Conclusions:

    • Treatment emphasizes topical therapies (corticosteroids, calcipotriol) and UV-B, with systemic agents reserved for severe cases.
    • Therapeutic goals include preserving skin integrity, providing symptom relief, and ensuring child safety.
    • Further research into pathogenesis and long-term outcomes is warranted for optimized pediatric psoriasis management.